- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Shandong Cancer Hospital and Institute
I alt 12676 resultater
-
Shandong Cancer Hospital and InstituteUkendtSentinel lymfeknudebiopsiKina
-
Shandong Cancer Hospital and InstituteUkendtKarcinom, ikke-småcellet lungeKina
-
Shandong Cancer Hospital and InstituteUkendt
-
Shandong Cancer Hospital and InstituteUkendt
-
Shandong Cancer Hospital and InstituteUkendt
-
Shandong Cancer Hospital and InstituteUkendt
-
Shandong Cancer Hospital and InstituteUkendt
-
Shandong Cancer Hospital and InstituteAstraZenecaUkendtIkke-småcellet lungekræft | Hjernemetastaser | EGFR-TKI resistent mutation | AZD9291
-
Shandong Cancer Hospital and InstituteBeiGeneAktiv, ikke rekrutterende
-
Jinming YuRekrutteringSmåcellet lungekræft i begrænset stadie | Ikke fremskridt efter førstelinjes kemoradioterapiKina
-
Zhiyong YuUkendtBrystkræft | Cirkulerende tumor-DNA | Neoadjuverende kemoterapiKina
-
Shandong Cancer Hospital and InstitutePeking University Cancer Hospital & InstituteUkendtIkke-småcellet lungekræft
-
Zhiyong YuIkke rekrutterer endnu
-
Zhiyong YuIkke rekrutterer endnuPatologiske resterende kræftcellerKina
-
Zhiyong YuUkendtBrystkræft | Kemoterapi | Endokrine brystsygdomme
-
Zhiyong YuUkendtBrystkræft | Neoadjuverende kemoterapi | Patologisk komplet respons
-
Lei ZHAORekrutteringIntrahepatisk cholangiocarcinomKina
-
Jinming YuRekrutteringIkke-småcellet lungekræft (NSCLC)Kina
-
Pingping SongIkke rekrutterer endnuIkke-småcellet lungekræft (NSCLC)Kina
-
Jinming YuRekrutteringIkke-småcellet lungekræft (NSCLC)Kina
-
Zhiyong YuIkke rekrutterer endnuHER2-positiv avanceret brystkræft
-
Rongjie TaoAfsluttetEffektivitet og sikkerhedKina
-
Zhiyong YuUkendtBrystkræft | Kemoterapi effekt | Sygdomsfri overlevelse
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Shandong Cancer Hospital and InstituteRekrutteringBrystkræft | Småcellet lungekræft | Kolorektal cancer | Avanceret solid tumor | Ikke-småcellet lungekræft | Planocellulær kræft i hoved og halsKina
-
Innolake BiopharmShandong Cancer Hospital and Institute; Shanghai East HospitalRekrutteringAvanceret solid tumorKina
-
Shandong Cancer Hospital and InstituteQilu Hospital of Shandong University; Shandong Provincial Hospital; The Affiliated...Ukendt
-
Shandong Cancer Hospital and InstituteJiangsu HengRui Medicine Co., Ltd.Aktiv, ikke rekrutterende
-
Jinming YuRoche Pharma AGUkendt
-
Shandong Cancer Hospital and InstituteJiangsu HengRui Medicine Co., Ltd.RekrutteringNeoadjuverende undersøgelse af Camrelizumab Plus Kemoterapi ved Triple Negative Breast Cancer (TNBC)Tredobbelt negativ brystkræftKina
-
Shandong Cancer Hospital and InstituteJiangsu HengRui Medicine Co., Ltd.UkendtIkke-småcellet lungekræftKina
-
Shandong Cancer Hospital and InstituteHenan Cancer Hospital; The Affiliated Hospital of Qingdao UniversityUkendt
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Tianjin Medical University Cancer Institute and Hospital; Shandong Cancer...RekrutteringTAA06 Injektion til behandling af patienter med B7-H3-positivt recidiverende/refraktært neuroblastomB7-H3-positivt recidiverende/ refraktært neuroblastomKina
-
The Second Hospital of Shandong UniversityShandong Cancer Hospital and Institute; Wuhan YZY Medical Science and Technology...UkendtSpiserørskræft TNM stadieinddeling Primær tumor (T) T3Kina
-
Shandong Cancer Hospital and InstituteThe First Affiliated Hospital of Nanchang UniversityRekrutteringNanchang Universitys første tilknyttede hospitalKina
-
Shandong UniversityCancer Institute and Hospital, Chinese Academy of Medical SciencesTrukket tilbage
-
Peking University People's HospitalPeking University Shougang Hospital; Shandong Cancer Hospital and InstituteRekruttering
-
Shandong UniversityCancer Institute and Hospital, Chinese Academy of Medical Sciences; Shandong... og andre samarbejdspartnereUkendtPurpura, trombocytopenisk, idiopatisk | Immun trombocytopeniKina
-
Yongsheng WangJiangsu HengRui Medicine Co., Ltd.RekrutteringLokalt avanceret brystkræft | Hormonreceptorpositiv, HER2-negativ brystkræftKina
-
Shandong Cancer Hospital and InstituteChia Tai Tianqing Pharmaceutical Group Co., Ltd.Ukendt
-
Shandong Cancer Hospital and InstituteChia Tai Tianqing Pharmaceutical Group Co., Ltd.UkendtIkke småcellet lungekræftKina
-
Jinming YuJiangsu HengRui Medicine Co., Ltd.UkendtMetastatisk brystkræft | HER2-positiv brystkræftKina
-
Rongjie TaoNational Natural Science Foundation of ChinaUkendt
-
Rongjie TaoNational Natural Science Foundation of ChinaUkendtTumorer i centralnervesystemetKina
-
Wei ZhaoCancer Institute and Hospital, Chinese Academy of Medical SciencesUkendtHæmatologiske neoplasmerKina
-
Rongjie TaoNational Natural Science Foundation of ChinaUkendtTumorer i centralnervesystemet
-
Zhejiang Cancer HospitalFudan University; Cancer Institute and Hospital, Chinese Academy of Medical... og andre samarbejdspartnereAfsluttetStadie III ikke-småcellet lungekræftKina
-
Shandong Cancer Hospital and InstituteCancer Institute and Hospital, Chinese Academy of Medical Sciences; RenJi... og andre samarbejdspartnereAfsluttet
-
Shandong University of Traditional Chinese MedicineShandong Institute of Science and Technology InformationIkke rekrutterer endnuPostoperativt delirium
-
Beijing Chao Yang HospitalWuhan University; Shandong Provincial Hospital; Shandong Cancer Hospital... og andre samarbejdspartnereUkendtPostoperative komplikationer | Endetarmskræft | Behandling | Neoplasma gentagelse, lokal | OverlevelsesrateKina
-
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.Peking University Cancer Hospital & InstituteUkendtSmåcellet lungekræft | PEG-rhG-CSFKina